This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
How can we address the challenges of opioid use in pregnancy?
Evaluating the Maternal Opioid Misuse (MOM) Model
Challenge
Opioid use in pregnancy is associated with high numbers of babies born with neonatal abstinence syndrome or neonatal opioid withdrawal syndrome. The Centers for Medicare & Medicaid Services awarded cooperative agreements to 10 state Medicaid agencies to implement the Maternal Opioid Misuse (MOM) Model. By supporting the coordination of clinical care and the integration of other critical services, the MOM Model has the potential to improve quality of care and reduce costs for mothers and infants.
Solution
Westat developed qualitative, process, and impact evaluation designs to conduct 10 individual model awardee evaluations and a cross-site evaluation. The MOM evaluation is based on a mixed-methods framework and includes numerous rounds of key informant interviews, patient focus groups, patient interviews, and qualitative data analysis using Dedoose.
Analysis of participant-level process data will provide characteristics of MOM enrollees, their experiences and service use, and ongoing examination of the outcomes associated with program participation. The implementation period will include impact analyses, making use of T-MSIS (Medicaid) data, vital statistics, and other awardee-specific or publicly available data to measure the model’s effects on quality, health outcomes, and costs.
For this 5-year evaluation, Westat is using innovative approaches such as a mixed-methods integration team, Photovoice, and journey mapping for capturing patient perspectives.
Results
The mixed-methods evaluation will determine the impact of the MOM Model on health outcomes, patient experiences, utilization, and cost for pregnant and postpartum Medicaid patients with opioid use disorder and their infants.
Learn more:
CMS website: Maternal Opioid Misuse (MOM) Model
Latest Annual Report:
Two Pager: Maternal Opioid Misuse (MOM) Model Evaluation of Implementation Year 2 (July 2022−June 2023) (PDF)
Full report: Evaluation of the Maternal Opioid Misuse (MOM) Model Third Annual Report (Implementation Year 2) (PDF)
Prior Evaluation Reports
Two Pager: At-A-Glance Report (PDF)
MOM Model Second Annual Evaluation Report (PDF)
Focus Areas
Behavioral Health Maternal Health Opioids Public HealthCapabilities
Evaluation and Mixed-Methods ResearchSenior Expert Contact
Meg Tucker
Principal Research Associate
-
Perspective
Public Health in Action: Westat APHA 2024 HighlightsNovember 2024
Westat staff made their mark at the 2024 American Public Health Association (APHA) Annual Meeting and Expo, which was held in Minneapolis, Minnesota, October 27-30.…
-
Expert Interview
Timely Data-Driven Solutions for Nursing HomesNovember 2024
The COVID-19 pandemic has had a devastating impact on the nursing home sector, resulting in hundreds of thousands of deaths of residents and staff and…
-
Perspective
Westat Work Shines at 2024 APHSA EMWB ConferenceSeptember 2024
Westat human services experts recently presented at the American Public Human Services Association (APHSA)’s Economic Mobility and Well-Being (EMWB) Conference in Portland, Oregon. At the…